Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adsorbed Tetanus Vaccine in Healthy Individuals Aged 18-43 Years
NCT07740733Phase 3Completed
- Sponsor
- Beijing Minhai Biological
- Start
- Feb 2024
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
A Phase 3 trial of tetanus toxoid in Tetanus, sponsored by Beijing Minhai Biological. Started Feb 2024; status: completed.
02
Drugs
tetanus toxoid
03
Conditions
Tetanus
Beyond the preview
Go deeper on NCT07740733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07740733.